Found: 15
Select item for more details and to access through your institution.
Patients’ knowledge about renal secondary effects of anti-tumoral drugs and renal protection measures.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 11, p. 1, doi. 10.1007/s00520-024-08956-8
- By:
- Publication type:
- Article
Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Onco-nephrology: Physicians' Expectations About a New Subspecialty.
- Published in:
- Journal of Cancer Education, 2023, v. 38, n. 3, p. 878, doi. 10.1007/s13187-022-02201-8
- By:
- Publication type:
- Article
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1678, doi. 10.3390/cancers14071678
- By:
- Publication type:
- Article
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1331, doi. 10.3390/cancers14051331
- By:
- Publication type:
- Article
Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2657, doi. 10.3390/cancers12092657
- By:
- Publication type:
- Article
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/3449660
- By:
- Publication type:
- Article
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3172, doi. 10.1002/cam4.5171
- By:
- Publication type:
- Article
Incidence, management, and outcome of lung cancer in patients with long‐term oxygen therapy.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 1, p. 36, doi. 10.1111/1759-7714.14692
- By:
- Publication type:
- Article
Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma.
- Published in:
- BJU International, 2023, v. 132, n. 5, p. 581, doi. 10.1111/bju.16129
- By:
- Publication type:
- Article
Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor Treatment.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 7, p. 1025, doi. 10.1007/s40262-024-01396-x
- By:
- Publication type:
- Article
FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 6, p. 579, doi. 10.1080/0284186X.2023.2216339
- By:
- Publication type:
- Article
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. 433, doi. 10.1093/oncolo/oyac262
- By:
- Publication type:
- Article
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
- Published in:
- Oncologist, 2022, v. 27, n. 12, p. 1041, doi. 10.1093/oncolo/oyac158
- By:
- Publication type:
- Article